Skip to main content

A Cross-Biomeasure Study to Optimize Antiretroviral Adherence Estimation.

Publication ,  Journal Article
Devanathan, AS; Poliseno, AJ; White, NR; Schauer, AP; Sykes, C; Weideman, AMK; Kilpatrick, KW; Hudgens, MG; Gay, CL; Rosen, EP; Dumond, JB ...
Published in: Journal of acquired immune deficiency syndromes (1999)
March 2025

Incomplete adherence to daily tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) reduces effectiveness. Adherence biomeasures (ie, drug concentrations in biological specimen) are more accurate than self-report. TDF/FTC's intracellular active metabolites (tenofovir-diphosphate; TFVdp and FTC-triphosphate; FTCtp) can be quantified in different types of blood samples to estimate adherence. To optimize adherence estimation, we investigated approaches to measure TFVdp and FTCtp in 4 blood matrices.Twelve HIV-negative, healthy volunteers were enrolled in a single-center, open-label, 3-phase, directly observed therapy study. LC-MS/MS methods quantified TFVdp/FTCtp in dried blood spots, volumetrically accurate microsampling, upper layer packed cells, and peripheral blood mononuclear cells (PBMCs). Noncompartmental analysis estimated half-lives and accumulation ratios. Correlations characterized relationships between clinical variables and exposure. Regression models were fit to determine concentrations associated with <4 and ≥4 doses/week; correct classification percentages were determined.Terminal half-life estimates of 3-4 vs 15-22 days distinguished between moderate-term (FTCtp in all samples; TFVdp in PBMCs) versus long-term (TFVdp in red blood cell-containing matrices) measures. Model-derived thresholds accurately categorized <4 and ≥4 doses/week when including both metabolites for 14- and 28-day dosing periods (81%-91% and 82%-85%, respectively). Within each classification and regression trees analyses containing both moderate- and long-term measures, dried blood spots exhibited highest accuracy to predict stable (74%-94%) and changing (42%-47%) adherence patterns.We demonstrate higher accuracy of moderate-term biomeasures to classify adherence over a 14-day period compared with long-term biomeasures to classify adherence over a 28-day period. Combined moderate- and long-term biomeasures predicted stable and changing adherence patterns, with dried blood spots exhibiting highest accuracy.

Duke Scholars

Published In

Journal of acquired immune deficiency syndromes (1999)

DOI

EISSN

1944-7884

ISSN

1525-4135

Publication Date

March 2025

Volume

98

Issue

3

Start / End Page

291 / 299

Related Subject Headings

  • Young Adult
  • Virology
  • Tenofovir
  • Tandem Mass Spectrometry
  • Organophosphates
  • Middle Aged
  • Medication Adherence
  • Male
  • Leukocytes, Mononuclear
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Devanathan, A. S., Poliseno, A. J., White, N. R., Schauer, A. P., Sykes, C., Weideman, A. M. K., … Cottrell, M. L. (2025). A Cross-Biomeasure Study to Optimize Antiretroviral Adherence Estimation. Journal of Acquired Immune Deficiency Syndromes (1999), 98(3), 291–299. https://doi.org/10.1097/qai.0000000000003570
Devanathan, Aaron S., Amanda J. Poliseno, Nicole R. White, Amanda P. Schauer, Craig Sykes, Ann Marie K. Weideman, Kayla W. Kilpatrick, et al. “A Cross-Biomeasure Study to Optimize Antiretroviral Adherence Estimation.Journal of Acquired Immune Deficiency Syndromes (1999) 98, no. 3 (March 2025): 291–99. https://doi.org/10.1097/qai.0000000000003570.
Devanathan AS, Poliseno AJ, White NR, Schauer AP, Sykes C, Weideman AMK, et al. A Cross-Biomeasure Study to Optimize Antiretroviral Adherence Estimation. Journal of acquired immune deficiency syndromes (1999). 2025 Mar;98(3):291–9.
Devanathan, Aaron S., et al. “A Cross-Biomeasure Study to Optimize Antiretroviral Adherence Estimation.Journal of Acquired Immune Deficiency Syndromes (1999), vol. 98, no. 3, Mar. 2025, pp. 291–99. Epmc, doi:10.1097/qai.0000000000003570.
Devanathan AS, Poliseno AJ, White NR, Schauer AP, Sykes C, Weideman AMK, Kilpatrick KW, Hudgens MG, Gay CL, Rosen EP, Dumond JB, Kashuba ADM, Cottrell ML. A Cross-Biomeasure Study to Optimize Antiretroviral Adherence Estimation. Journal of acquired immune deficiency syndromes (1999). 2025 Mar;98(3):291–299.

Published In

Journal of acquired immune deficiency syndromes (1999)

DOI

EISSN

1944-7884

ISSN

1525-4135

Publication Date

March 2025

Volume

98

Issue

3

Start / End Page

291 / 299

Related Subject Headings

  • Young Adult
  • Virology
  • Tenofovir
  • Tandem Mass Spectrometry
  • Organophosphates
  • Middle Aged
  • Medication Adherence
  • Male
  • Leukocytes, Mononuclear
  • Humans